chr1-102888872-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000370096.9(COL11A1):ā€‹c.4512T>Cā€‹(p.Gly1504=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.746 in 1,611,910 control chromosomes in the GnomAD database, including 457,887 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.65 ( 35478 hom., cov: 32)
Exomes š‘“: 0.76 ( 422409 hom. )

Consequence

COL11A1
ENST00000370096.9 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.219
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 1-102888872-A-G is Benign according to our data. Variant chr1-102888872-A-G is described in ClinVar as [Benign]. Clinvar id is 258466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-102888872-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.783 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL11A1NM_001854.4 linkuse as main transcriptc.4512T>C p.Gly1504= synonymous_variant 60/67 ENST00000370096.9 NP_001845.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkuse as main transcriptc.4512T>C p.Gly1504= synonymous_variant 60/671 NM_001854.4 ENSP00000359114 P1P12107-1

Frequencies

GnomAD3 genomes
AF:
0.651
AC:
98840
AN:
151896
Hom.:
35469
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.315
Gnomad AMI
AF:
0.780
Gnomad AMR
AF:
0.795
Gnomad ASJ
AF:
0.803
Gnomad EAS
AF:
0.742
Gnomad SAS
AF:
0.645
Gnomad FIN
AF:
0.806
Gnomad MID
AF:
0.804
Gnomad NFE
AF:
0.780
Gnomad OTH
AF:
0.712
GnomAD3 exomes
AF:
0.737
AC:
184970
AN:
251086
Hom.:
70321
AF XY:
0.739
AC XY:
100325
AN XY:
135710
show subpopulations
Gnomad AFR exome
AF:
0.304
Gnomad AMR exome
AF:
0.825
Gnomad ASJ exome
AF:
0.794
Gnomad EAS exome
AF:
0.720
Gnomad SAS exome
AF:
0.649
Gnomad FIN exome
AF:
0.808
Gnomad NFE exome
AF:
0.777
Gnomad OTH exome
AF:
0.774
GnomAD4 exome
AF:
0.756
AC:
1103516
AN:
1459896
Hom.:
422409
Cov.:
45
AF XY:
0.755
AC XY:
548116
AN XY:
726384
show subpopulations
Gnomad4 AFR exome
AF:
0.293
Gnomad4 AMR exome
AF:
0.822
Gnomad4 ASJ exome
AF:
0.796
Gnomad4 EAS exome
AF:
0.699
Gnomad4 SAS exome
AF:
0.653
Gnomad4 FIN exome
AF:
0.804
Gnomad4 NFE exome
AF:
0.774
Gnomad4 OTH exome
AF:
0.744
GnomAD4 genome
AF:
0.650
AC:
98867
AN:
152014
Hom.:
35478
Cov.:
32
AF XY:
0.655
AC XY:
48665
AN XY:
74294
show subpopulations
Gnomad4 AFR
AF:
0.314
Gnomad4 AMR
AF:
0.795
Gnomad4 ASJ
AF:
0.803
Gnomad4 EAS
AF:
0.742
Gnomad4 SAS
AF:
0.645
Gnomad4 FIN
AF:
0.806
Gnomad4 NFE
AF:
0.780
Gnomad4 OTH
AF:
0.715
Alfa
AF:
0.753
Hom.:
58877
Bravo
AF:
0.639
Asia WGS
AF:
0.683
AC:
2374
AN:
3478
EpiCase
AF:
0.781
EpiControl
AF:
0.785

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxSep 29, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Fibrochondrogenesis 1 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 22, 2021- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Stickler syndrome type 2 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 22, 2021- -
Hearing loss, autosomal dominant 37 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 22, 2021- -
Marshall syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 22, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
4.3
DANN
Benign
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1763347; hg19: chr1-103354428; COSMIC: COSV62176467; COSMIC: COSV62176467; API